MARKET

YDES

YDES

YD Bio Ltd
NASDAQ
5.18
+0.12
+2.27%
Closed 11:44 05/15 EDT
OPEN
5.36
PREV CLOSE
5.06
HIGH
5.36
LOW
5.18
VOLUME
2.13K
TURNOVER
--
52 WEEK HIGH
25.00
52 WEEK LOW
4.730
MARKET CAP
366.55M
P/E (TTM)
-5.2379
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at YDES last week (0504-0508)?
Weekly Report · 5d ago
Weekly Report: what happened at YDES last week (0427-0501)?
Weekly Report · 05/04 10:21
YD Bio Limited GAAP EPS of -$0.12, revenue of $0.6M
Seeking Alpha · 04/30 22:03
YD Bio FY25 net loss widens to $8.3 million; revenue rises 17% to $596,817
PUBT · 04/30 21:46
YD Bio Limited Reports Full Year 2025 Financial Results
Barchart · 04/30 17:00
Weekly Report: what happened at YDES last week (0420-0424)?
Weekly Report · 04/27 10:24
Weekly Report: what happened at YDES last week (0413-0417)?
Weekly Report · 04/20 10:19
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday
Benzinga · 04/17 14:09
More
About YDES
YD Bio Limited is a biopharmaceutical company. The Company is focused on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of diseases with unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. It is focused on advancing a diversified portfolio of healthcare solutions across oncology diagnostics, regenerative medicine and clinical trial support. It is a supplier of clinical trial drugs and has expanded into the development and distribution of post-market auxiliary products. Its core programs include Blood-Based Cancer Detection, Stem Cell- and Exosome-Based Ophthalmology Therapies, and Clinical Trial and AncillaryServices. It is developing proprietary DNA methylation-based detection technology for a range of cancers, which includes a screening test for the early detection of pancreatic cancer and a monitoring test for recurrent breast cancer.

Webull offers YD Bio Ltd stock information, including NASDAQ: YDES real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, YDES stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading YDES stock methods without spending real money on the virtual paper trading platform.